These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12778752)

  • 1. [Study on the hepatocytic cell targetability of liposomes].
    Hou XP; Wang L; Wang XT; Li S
    Yao Xue Xue Bao; 2003 Feb; 38(2):143-6. PubMed ID: 12778752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
    Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
    Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver.
    Rotundo RF; Rebres RA; Mckeown-Longo PJ; Blumenstock FA; Saba TM
    Hepatology; 1998 Aug; 28(2):475-85. PubMed ID: 9696014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on third-type immunoliposomes loaded drugs and the targeting in vitro and in vivo].
    Hou XP; Zhang YF; Xie SS; Hu X
    Yao Xue Xue Bao; 2001 Jul; 36(7):539-42. PubMed ID: 12585089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes.
    Ise H; Sugihara N; Negishi N; Nikaido T; Akaike T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):172-82. PubMed ID: 11444822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin.
    Wang SN; Deng YH; Xu H; Wu HB; Qiu YK; Chen DW
    Eur J Pharm Biopharm; 2006 Jan; 62(1):32-8. PubMed ID: 16226883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of the EPC and HEPC sterically stabilized doxorubicin liposomes and further studies on pharmacokinetics in rats].
    Yu M; Wang Y; Shu G; Zhu Z; Fang S; Wang L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):597-9. PubMed ID: 18693438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
    Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
    J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors.
    Di Stefano G; Fiume L; Bolondi L; Lanza M; Pariali M; Chieco P
    Liver Int; 2005 Aug; 25(4):854-60. PubMed ID: 15998437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of different phospholipids on the stabilities of doxorubicin liposomes in vitro and in vivo].
    Wang L; Hou BG; Hou XP; Yu ML; Yang JS
    Yao Xue Xue Bao; 2001 Jun; 36(6):444-7. PubMed ID: 12585130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro.
    Sawant RM; Cohen MB; Torchilin VP; Rokhlin OW
    J Drug Target; 2008 Aug; 16(7):601-4. PubMed ID: 18686131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of asialoglycoprotein receptor expression in the proliferative state of hepatocytes.
    Hirose S; Ise H; Uchiyama M; Cho CS; Akaike T
    Biochem Biophys Res Commun; 2001 Sep; 287(3):675-81. PubMed ID: 11563848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes.
    Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
    Gene Ther; 1995 Dec; 2(10):784-8. PubMed ID: 8750019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
    Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
    Bernardes GJ; Kikkeri R; Maglinao M; Laurino P; Collot M; Hong SY; Lepenies B; Seeberger PH
    Org Biomol Chem; 2010 Nov; 8(21):4987-96. PubMed ID: 20820666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on nerve growth factor liposomes on crossing blood-brain barrier in vitro and in vivo].
    Xie Y; Ye LY; Cui W; Xu K; Zhang XB; Lou JN; Hou XP
    Yao Xue Xue Bao; 2004 Nov; 39(11):944-8. PubMed ID: 15696939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterically stable liposomes improve the therapeutic effect of hepatic stimulator substance on fulminant hepatic failure in rats.
    Li F; Sun JY; Liu M; Lu WY; Wang JY; Shi JY
    Biochem Pharmacol; 2011 Sep; 82(5):556-65. PubMed ID: 21664898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synergistic role between rhIL-2 and adriamycin long circulating temperature-sensitive liposome in targeting therapy on tumor].
    Dong LF; Mei HS; Song SX; Lu ZJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):296-300. PubMed ID: 15862144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.